The MCW Cancer Center research efforts are focused around five programs that leverage institutional and partner investments to build on existing scientific expertise.
These Research Programs were selected because of strong leadership, current and potential funding and faculty opportunities and suitability for collaboration between projects and investigators.
Cancer Susceptibility & Chemoprevention (CSC)
Biological and chemical causes, preventions, and treatments of cancer.
Program Leader: Gary Stoner, PhD
Cancer Cell Signaling & Metabolism (CCSM)
Characteristics of cancer cells -- signal transduction and alternations in functions and regulations.
Program Leaders: Balaraman Kalyanaraman, PhD, and Carol Williams, PhD
Angiogenesis, Metastasis & the Tumor Microenvironment (AMTM)
Interaction of cancer cells with their environment and the progression of cancer.
Program Leaders: Michael Dwinell, PhD and William Campbell, PhD
Cancer Imaging (CI)
Understanding how to detect cancer earlier and determining the precise locations and stages of cancer.
Program Leaders: Kathleen Schmainda, PhD and Shi-Jiang Li, PhD
Hematologic Malignancy & Transplantation (HMT)
Understanding how transferring cells from one person to another can kill cancer cells, and discovering new ways to reset the immune system.
Program Leader: William Drobyski, MD
Population Sciences (PS)
Reducing cancer incidence and rates of death across all demographic groups.
Program Leaders: Ann Nattinger, MD, MPH, and Joan Neuner, MD, MPH
Experimental Therapeutics (ET)
Translating bench research into new clinical therapies.
Program Leader: James Thomas, MD, PhD